| Filofteia Badila, DDS | |
|
819 S Salina St, Syracuse, NY 13202-3536 | |
| (315) 476-7921 | |
| (315) 475-1448 |
| Full Name | Filofteia Badila |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 819 S Salina St, Syracuse, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023070133 | NPI | - | NPPES |
| 01495472 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 045166 (New York) | Primary |
| Entity Name | Syracuse Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497796353 PECOS PAC ID: 0143121327 Enrollment ID: O20040120000443 |
News Archive
Today, Lung Cancer Alliance (LCA) called 2010 "a watershed year" for lung cancer that included increased research funding, additional Congressional support, a new national coalition of key policy organizations, and the validation of CT screening - a convergence of forces that can reverse the historic underfunding and neglect of lung cancer.
"CVS Caremark Corp (CVS.N) has been the subject of a U.S. Federal Trade Commission investigation over some of its business practices since August, the company said on Thursday," Reuters reports. "Various groups have asked the government to look into CVS Caremark's practices since drugstore chain CVS bought pharmacy benefits management business Caremark Rx Inc in March 2007. They claim that changes to services in the pharmacy benefits business since the acquisition have led to higher prices, compromised quality of care and pushed patients to choose CVS drugstores over other pharmacies."
NewLink Genetics Corporation today announced that additional data from its Phase 2 clinical trial of the company's investigational HyperAcute® Pancreas cancer immunotherapy will be presented during a poster session at the American Society of Clinical Oncology 2011 Gastrointestinal Cancers Symposium in San Francisco, California.
Ario Pharma Ltd, the Cambridge biopharmaceutical company developing innovative new approaches to treat respiratory disease, announced today that it has commenced a Phase IIa study of its TRPV1 antagonist, XEN-0501, for the treatment and prevention of cough in patients with chronic obstructive pulmonary disease (COPD). Persistent cough in COPD and other respiratory conditions present as a huge unmet medical need, with novel therapies urgently needed to improve the quality of life of patients.
The number of teens taking and overdosing from benzodiazepines, commonly prescribed anxiety medications, has risen dramatically over the past decade, according to a national study coauthored by Rutgers researchers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Filofteia Badila, DDS 819 S. Salina Street, Syracuse, NY 13202 Ph: (315) 476-7921 | Filofteia Badila, DDS 819 S Salina St, Syracuse, NY 13202-3536 Ph: (315) 476-7921 |
News Archive
Today, Lung Cancer Alliance (LCA) called 2010 "a watershed year" for lung cancer that included increased research funding, additional Congressional support, a new national coalition of key policy organizations, and the validation of CT screening - a convergence of forces that can reverse the historic underfunding and neglect of lung cancer.
"CVS Caremark Corp (CVS.N) has been the subject of a U.S. Federal Trade Commission investigation over some of its business practices since August, the company said on Thursday," Reuters reports. "Various groups have asked the government to look into CVS Caremark's practices since drugstore chain CVS bought pharmacy benefits management business Caremark Rx Inc in March 2007. They claim that changes to services in the pharmacy benefits business since the acquisition have led to higher prices, compromised quality of care and pushed patients to choose CVS drugstores over other pharmacies."
NewLink Genetics Corporation today announced that additional data from its Phase 2 clinical trial of the company's investigational HyperAcute® Pancreas cancer immunotherapy will be presented during a poster session at the American Society of Clinical Oncology 2011 Gastrointestinal Cancers Symposium in San Francisco, California.
Ario Pharma Ltd, the Cambridge biopharmaceutical company developing innovative new approaches to treat respiratory disease, announced today that it has commenced a Phase IIa study of its TRPV1 antagonist, XEN-0501, for the treatment and prevention of cough in patients with chronic obstructive pulmonary disease (COPD). Persistent cough in COPD and other respiratory conditions present as a huge unmet medical need, with novel therapies urgently needed to improve the quality of life of patients.
The number of teens taking and overdosing from benzodiazepines, commonly prescribed anxiety medications, has risen dramatically over the past decade, according to a national study coauthored by Rutgers researchers.
› Verified 8 days ago
Jennifer Lonnen, DDS Dentist Medicare: Medicare Enrolled Practice Location: 750 E. Adams Street, Syracuse, NY 13210 Phone: 315-464-4148 | |
Kelvin O. White, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1700 James St, Syracuse, NY 13206 Phone: 315-478-9928 | |
Dr. Joan Lura Armstrong, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 437 Allen St, Syracuse, NY 13210 Phone: 315-422-3307 | |
Dr. Jeffrey Brian Stannard, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1001 E Genesee St, Syracuse, NY 13210 Phone: 315-478-1001 Fax: 315-471-1683 | |
Dr. Navid Rashidi Keikanloo, D.D.S Dentist Medicare: Medicare Enrolled Practice Location: 2800 Court St, Syracuse, NY 13208 Phone: 315-455-5934 Fax: 315-455-5935 | |
Dr. Michael Burke Mcgrath, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5108 Velasko Rd, Syracuse, NY 13215 Phone: 315-478-5719 Fax: 315-478-5734 |